NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon‐α2b Treatment
ABSTRACT Background We investigated the role of Nuclear Receptor Binding SET Domain Protein 2 (NSD2) and microRNAs (miRNAs) in melanoma de‐differentiation following Romidepsin and Interferon‐α2b (RI) treatment. Melanoma is the most lethal form of skin cancer, and despite advancements in therapy, tre...
Saved in:
| Main Authors: | Alessandro De Santis, Lucrezia De Santis, Francesca Rossi, Silvia Gasparini, Valerio Licursi, Vito Antonio Amico, Imerio Capone, Alessandra Fragale, Stefania D'atri, Lucia Gabriele, Carlo Presutti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70917 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degraders
by: Suresh Chava, et al.
Published: (2025-06-01) -
Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption
by: Yue Xu, et al.
Published: (2024-12-01) -
Species-specific gene regulatory network rewiring mediated by the GATA-type regulator NsdD in Aspergillus
by: Heungyun Moon, et al.
Published: (2025-08-01) -
Study on the regulatory mechanism of NsdAsr on rimocidin biosynthesis in Streptomyces rimosus M527
by: Yawen Xie, et al.
Published: (2025-07-01) -
Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations
by: Xing Jin, et al.
Published: (2024-12-01)